The reduction in price target by BMO Capital suggests a less optimistic outlook on Stem, Inc.'s stock value in the short term, potentially leading to a negative impact on its stock price. The maintenance of a Market Perform rating indicates that the analyst does not see significant downside or upside from the current price level, but the lowered price target could influence investor sentiment negatively.